Patents by Inventor Anindita Chakrabarty

Anindita Chakrabarty has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Data Storage Device and Method for Executing a Low-Priority Speculative Read Command from a Host
    Publication number: 20230315335
    Abstract: A data storage device receives a speculative read command from a host identifying logical block addresses. The speculative read command is not required be to executed within a certain amount of time or even at all. The data storage device at least partially executes the speculative read command in response to determining that such execution will not reduce performance of the data storage device. At least partially executing the speculative read command causes data associated with at least some of the logical block addresses to be read from the non-volatile memory and stored in at least one buffer. Other embodiments are possible, and each of the embodiments can be used alone or together in combination.
    Type: Application
    Filed: March 31, 2022
    Publication date: October 5, 2023
    Applicant: Western Digital Technologies, Inc.
    Inventors: Abhinandan Venugopal, Amit Sharma, Anindita Chakrabarty
  • Combinations of kinase inhibitors for the treatment of cancer
    Patent number: 9011863
    Abstract: The present invention provides methods of treating cancer by administering a compound of formula I, optionally as a pharmaceutically acceptable salt, solvate and/or hydrate thereof, in combination with an inhibitor that targets HER2 and/or HER3.
    Type: Grant
    Filed: July 8, 2011
    Date of Patent: April 21, 2015
    Assignee: Exelixis, Inc.
    Inventors: Dana T. Aftab, Carlos L. Arteaga, Veronique Blanc, Anindita Chakrabarty, Marielle Chiron-Blonde, Celine Nicolazzi, Ariella Hanker, Loic Vincent
  • Combinations of Kinase Inhibitors for the Treatment of Cancer
    Publication number: 20140271665
    Abstract: The present invention provides methods of treating cancer by administering a compound of formula I, optionally as a pharmaceutically acceptable salt, solvate and/or hydrate thereof, in combination with an inhibitor that targets HER2 and/or HER3.
    Type: Application
    Filed: July 8, 2011
    Publication date: September 18, 2014
    Applicants: Exelixis, Inc., Sanofi, Vanderbilt University
    Inventors: Dana T. Aftab, Carlos L. Arteaga, Veronique Blanc, Anindita Chakrabarty, Marielle Chiron-Blonde, Celine Nicolazzi, Ariella Hanker, Loic Vincent